510(k) Report

510(k) · Cleared

Cleared

Yumizen H550

K260781510(k) TraditionalCleared Sep 14, 2026188-day reviewClass II21 CFR 864.5220

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Horiba Abx Sas · GKZ Counter, Differential Cell

Cleared on Sep 14, 2026 as substantially equivalent to K232946 (Horiba Abx Sas, 2024) after a 188-day review. Its family tree reaches back 4 generations to 2004.

Decided
Sep 14, 2026
Review
188 days
Class
Class II
Product code
GKZ
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K040073 (2004). No later device cites it as a predicate yet.

  1. Root · 4 generations backK040073 Sysmex Automated Hematology Analyzer, XE-2100 Series (XE-2100…Sysmex America, Inc. · 2004
  2. 3 generations backK071967 Sysmex XE-5000Sysmex America, Inc. · 2007 · Recalled
  3. 2 generations backK112605 Sysmex XN-SeriesSysmex America, Inc. · 2012 · Recalled
  4. 1 generation backK232946 Yumizen H2500Horiba Abx Sas · 2024
  5. This deviceK260781 Yumizen H550Horiba Abx Sas · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K040073Sysmex Automated Hematology Analyzer, XE-2100 Series (XE-2100, XE-2100L)Sysmex America, Inc.2004—
−3K071967Sysmex XE-5000Sysmex America, Inc.20071
−2K112605Sysmex XN-SeriesSysmex America, Inc.20122
−1K232946Yumizen H2500Horiba Abx Sas2024—
0 (this device)K260781Yumizen H550Horiba Abx Sas2026—
FIG. 1 — Lineage of K260781, 2004–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GKZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GKZ device

  1. #1 K250943 Sysmex XR-Series (XR-10) Automated Hematology…score 13.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K232946Yumizen H2500
Summary page 15
…n K260781 V. Substantial Equivalence Information A. Predicate Device Name(s) Yumizen H2500 B. Predicate 510(k) Number(s) K232946 C. Comparison with Predicate Table 2 - Comparison with predicate Device & Predicate K2607…
Horiba Abx Sas2024—
†K052007Abx Pentra 400 Clinical Chemistry Analyzer (Option: I.S.E. Module)Horiba Abx20056

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 2 companies; a new generation was cleared every 4.9 years on median.
  • 2 of the 4 ancestors have a recall of any class.

How does its category compare?

All GKZ devices

GKZ Counter, Differential Cell: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · GKZ

4in 2025

2007: 62008: 62009: 62010: 42011: 32012: 32013: 12014: 32015: 32016: 32017: 42018: 32019: 52020: 12022: 32023: 42024: 32025: 42026 (partial year): 4
2007high 6 (2007) · low 0 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GKZ

108in 2025

2007: 117 days median2008: 99 days median2009: 147 days median2010: 290 days median2011: 315 days median2012: 408 days median2014: 165 days median2015: 273 days median2016: 198 days median2017: 280 days median2018: 270 days median2019: 210 days median2022: 638 days median2023: 329 days median2024: 157 days median2025: 108 days median2026 (partial year): 254 days median
2007high 638 (2022) · low 99 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GKZ

1in 2025

2007: 372008: 52009: 132010: 272011: 282012: 72013: 62015: 32016: 32017: 32018: 2, 2 Class I2019: 22020: 12022: 42023: 12025: 1
2007high 37 (2007) · low 0 (2014)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · GKZ

77in 2025

2007: 2682008: 9252009: 5592010: 8962011: 2,9052012: 2,9592013: 3,0702014: 3,1122015: 1,9722016: 3,3382017: 2292018: 4972019: 9082020: 3422021: 3912022: 1982023: 1552024: 1152025: 77
2007high 3,338 (2016) · low 77 (2025)2025

MAUDE reports naming product code GKZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611737268
20086995925
2009614713559
2010429027896
20113315282,905
2012340872,959
20131—63,070
2014316503,112
2015327331,972
2016319833,338
201742803229
201832702 (2)497
201952102908
20201—1342
20210—0391
202236384198
202343291155
202431570115
20254108177
202642540—

What is it indicated for?

Yumizen H550 analyzers classify and enumerate the following parameters in whole blood: WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW-CV, RDW-SD, PLT, MPV, LYM#, LYM%, MON#, MON%, NEU#, NEU%, EOS#, EOS%, BAS#, BAS%, IMG#, IMG%. Yumizen H550 analyzers provide information for in vitro diagnostic use in clinical laboratories. Yumizen H550 analyzers are used for screening a physiological state (quantitative or qualitative hematology abnormality detection) or a…

Read the full statement (163 words)

Yumizen H550 analyzers classify and enumerate the following parameters in whole blood:

WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW-CV, RDW-SD, PLT, MPV, LYM#, LYM%, MON#, MON%, NEU#, NEU%, EOS#, EOS%, BAS#, BAS%, IMG#, IMG%.

Yumizen H550 analyzers provide information for in vitro diagnostic use in clinical laboratories.

Yumizen H550 analyzers are used for screening a physiological state (quantitative or qualitative hematology abnormality detection) or a pathological state of patient populations found in clinical laboratories.

Yumizen H550 analyzer are quantitative for parameters measurement and qualitative for alarms detection.

Yumizen H550 analyzers are intended to perform tests on the following specimens:

■ Venous blood

■ Capillary blood

collected in K2-EDTA and K3-EDTA anticoagulant.

Yumizen H550 analyzers are intended to perform tests on the following specimens:

Pediatric

■ New born: from birth to 28 days

■ Infant: from 29 days to 2 years

■ Children: from 2 years to 12 years

■ Adolescent: from 12 years to 21 years

Adult population

■ Above 21 years

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K260781: Yumizen H550.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260781

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026